Atlas Trials

Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)

Clinical trial NCT01991418 · COMPLETED

Trial details

NCT number
NCT01991418
Sponsor
Hunan Province Tumor Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage IIIA
Start date
2013-05-01
Primary completion
2016-02-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.